VITAMIN D DEFICIENCY AS A RISK FACTOR FOR PREECLAMPSIA: THE ROLE OF VITAMIN D RECEPTOR AND CYTOCHROME P450 FAMILY 27 SUBFAMILY B MEMBER 1

Poladych I. V., Govsieiev D. O.

VITAMIN D DEFICIENCY AS A RISK FACTOR FOR PREECLAMPSIA: THE ROLE OF VITAMIN D RECEPTOR AND CYTOCHROME P450 FAMILY 27 SUBFAMILY B MEMBER 1


Show/Download

About the author:

Poladych I. V., Govsieiev D. O.

Heading:

CLINICAL AND EXPERIMENTAL MEDICINE

Type of article:

Scientific article

Annotation:

Preeclampsia is a serious pregnancy complication that can have dangerous consequences for both the mother and the fetus. It is associated with vascular dysregulation, hypertension, and the potential development of complications such as preterm birth and intrauterine growth restriction. One of the potential risk factors for preeclampsia is vitamin D deficiency, as confirmed by our study involving 98 pregnant women at the Kyiv Perinatal Center. It was found that low vitamin D levels (<20 ng/mL) were more frequently observed in younger women (28,86±0,67 years) with an increased body mass index (27,85±0,34 kg/m²). Analysis of placental tissue revealed reduced expression of the vitamin D receptor (VDR) gene (0,95 (0,91–1,08)) and CYP27B1 (1,04 (0,96–1,12)), as well as decreased levels of the corresponding VDR (2,32 (1,11–2,52) ng/mL) and CYP27B1 (4,34 (4,20–5,15) ng/mL) proteins. Vitamin D deficiency was associated with a more severe course of preeclampsia (58,3% of cases) and its early onset (<34 weeks in 63,9% of women). The findings highlight the importance of regular monitoring of vitamin D levels in pregnant women and timely correction of its deficiency to reduce the risk of preeclampsia and improve pregnancy outcomes.

Tags:

CYP27B1, placenta, preeclampsia, VDR, vitamin D, vitamin D deficiency

Bibliography:

  1. Nirupama R, Divyashree S, Janhavi P, Muthukumar SP, Ravindra PV. Preeclampsia: Pathophysiology and management. J Gynecol Obstet Hum Reprod. 2021;50(2):101975. DOI: 10.1016/j.jogoh.2020.101975.
  2. Tomimatsu T, Mimura K, Matsuzaki S, Endo M, Kumasawa K, Kimura T. Preeclampsia: Maternal Systemic Vascular Disorder Caused by Generalized Endothelial Dysfunction Due to Placental Antiangiogenic Factors. Int J Mol Sci. 2019;20(17):4246. DOI: 10.3390/ijms20174246.
  3.  Gyselaers W. Preeclampsia Is a Syndrome with a Cascade of Pathophysiologic Events. J Clin Med. 2022;9(7):2245. DOI: 10.3390/jcm 9072245.
  4. Suresh S, Patel E, Mueller A, Morgan J, Lewandowski WL, Verlohren S, et al. The Additive Role of Angiogenic Markers for Women with Confirmed Preeclampsia. Am J Obstet Gynecol 2023;228:573.e1–11.
  5. Kiely ME, Wagner CL, Roth DE. Vitamin D in pregnancy: Where we are and where we should go. J Steroid Biochem Mol Biol. 2020;201:105669. DOI: 10.1016/j.jsbmb.2020.105669.
  6. Ni M, Zhang Q, Zhao J, Shen Q, Yao D, Wang T, et al. Relationship between maternal vitamin D status in the first trimester of pregnancy and maternal and neonatal outcomes: a retrospective single center study. BMC Pediatr. 2021;21(1):330. DOI: 10.1186/s12887-021-02730-z.
  7. Morales-Suárez-Varela M, Uçar N, Soriano JM, Llopis-Morales A, Sanford BS, Grant WB. Vitamin D-Related Risk Factors for Maternal Morbidity and Mortality during Pregnancy: Systematic Review and Meta-Analysis. Nutrients. 2022;14(19):4124. DOI: 10.3390/nu14194124.
  8. Mansur JL, Oliveri B, Giacoia E, Fusaro D, Costanzo PR. Vitamin D: Before, during and after Pregnancy: Effect on Neonates and Children. Nutrients. 2022;14(9):1900. DOI: 10.3390/nu14091900.
  9. Vivanti AJ, Monier I, Salakos E, Elie C, Tsatsaris V, Senat MV, et al. Vitamin D and pregnancy outcomes: Overall results of the FEPED study. J Gynecol Obstet Hum Reprod. 2020;49(8):101883. DOI: 10.1016/j.jogoh.2020.101883.
  10. Wang H, Zhang F, Li B, Fu M, Shan X, Ma Y. Three-stage pattern of rapid increase, plateau, and subsequent decline in vitamin D concentration during pregnancy among Chinese women: a large-scale survey. Front Nutr. 2023;10:1238389. DOI: 10.3389/fnut.2023.1238389.
  11. Mao D, Yuen LY, Ho CS, Wang CC, Tam CH, Chan MH, et al. The Association of Prenatal Vitamin D Status With Pregnancy and Neonatal Outcomes. J Endocr Soc. 2023;8(1):bvad142. DOI: 10.1210/jendso/bvad142.
  12. Mao D, Yuen LY, Ho CS, Wang CC, Tam CH, Chan MH, et al. Maternal and Neonatal 3-epi-25-hydroxyvitamin D Concentration and Factors Influencing Their Concentrations. J Endocr Soc. 2021;6(1):bvab170. DOI: 10.1210/jendso/bvab170.
  13. Pankiewicz K, Fijałkowska A, Issat T, Maciejewski TM. Insight into the Key Points of Preeclampsia Pathophysiology: Uterine Artery Remodeling and the Role of MicroRNAs. Int J Mol Sci. 2021;22(6):3132. DOI: 10.3390/ijms22063132.
  14. Chiarello DI, Abad C, Rojas D, Toledo F, Vázquez CM, Mate A, et al. Oxidative stress: Normal pregnancy versus preeclampsia. Biochim Biophys Acta Mol Basis Dis. 2020;1866(2):165354. DOI: 10.1016/j.bbadis.2018. 12.005.
  15. Rana S, Burke SD, Karumanchi SA. Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders. Am J Obstet Gynecol. 2022;226(2S):S1019-S1034. DOI: 10.1016/j.ajog.2020. 10.022.
  16. Benachi A, Baptiste A, Taieb J, Tsatsaris V, Guibourdenche J, Senat MV, et al. Relationship between vitamin D status in pregnancy and the risk for preeclampsia: A nested case-control study. Clin Nutr. 2020;39(2):440-446. DOI: 10.1016/j.clnu.2019.02.015.
  17. Raia-Barjat T, Sarkis C, Rancon F, Thibaudin L, Gris JC, Alfaidy N, et al. Vitamin D deficiency during late pregnancy mediates placentaassociated complications. Sci Rep. 2021;11(1):20708. DOI: 10.1038/s41598-021-00250-5.
  18. Aguilar-Cordero MJ, Lasserrot-Cuadrado A, Mur-Villar N, León-Ríos XA, Rivero-Blanco T, Pérez-Castillo IM. Vitamin D, preeclampsia and prematurity: A systematic review and meta-analysis of observational and interventional studies. Midwifery. 2020;87:102707. DOI: 10.1016/j.midw. 2020.102707.
  19. Yuan Y, Tai W, Xu P, Fu Z, Wang X, Long W, et al. Association of maternal serum 25-hydroxyvitamin D concentrations with risk of preeclampsia: a nested case-control study and meta-analysis. J Matern Fetal Neonatal Med. 2021;34(10):1576-1585. DOI: 10.1080/14767058.2019.1640675.
  20. Hu KL, Zhang CX, Chen P, Zhang D, Hunt S. Vitamin D Levels in Early and Middle Pregnancy and Preeclampsia, a Systematic Review and Meta-Analysis. Nutrients. 2022;14(5):999. DOI: 10.3390/nu14050999.
  21. Dahma G, Neamtu R, Nitu R, Gluhovschi A, Bratosin F, Grigoras ML, et al. The Influence of Maternal Vitamin D Supplementation in Pregnancies Associated with Preeclampsia: A Case-Control Study. Nutrients. 2022;14(15):3008. DOI: 10.3390/nu14153008.
  22. Huang XM, Liu YH, Zhang H, Cao Y, Dou WF, Duan DD, et al. Dietary and serum vitamin D and preeclampsia risk in Chinese pregnant women: a matched case-control study. Br J Nutr. 2022;128(1):84-92. DOI: 10.1017/S0007114521002956.
  23. MOZ Ukrainy. Nakaz MOZ Ukrainy № 151 Pro zatverdzhennia Unifikovanyi klinichnyi protokol pervynnoi, vtorynnoi (spetsializovanoi) ta tretynnoi (vysokospetsializovanoi) medychnoi dopomohy Hipertenzyvni rozlady pid chas vahitnosti polohiv ta u pislyapolohovomu periodi. Kyyiv: MOZ Ukrainy; 2022. 56 s. Dostupno: https://www.dec.gov.ua/wp-content/uploads/2022/ 01/2022_151_ykpmd_giprozlvagitn.pdf. [in Ukrainian].
  24. Rouhani P, Mokhtari E, Lotfi K, Saneei P. The association between circulating 25-hydroxyvitamin D levels and preeclampsia: a systematic review and dose-response meta-analysis of epidemiologic studies with GRADE assessment. Nutr Rev. 2023;81(10):1267-1289. DOI: 10.1093/nutrit/nuad006.
  25. Ashley B, Simner C, Manousopoulou A, Jenkinson C, Hey F, Frost JM, et al. Placental uptake and metabolism of 25(OH)vitamin D determine its activity within the fetoplacental unit. Elife. 2022;11:e71094. DOI: 10.7554/eLife.71094.
  26. Verlohren S, Droge LA. The diagnostic value of angiogenic and antiangiogenic factors in differential diagnosis of preeclampsia. Am J Obstet Gynecol. 2020;226:S1048-1058.
  27. Zhou Q, Wu Y, Zhang D. Exploring the role of T helper subgroups and their cytokines in the development of pregnancy-induced hypertension. Front Immunol. 2023;14:1126784. DOI: 10.3389/fimmu.2023.1126784.
  28. Varshney S, Adela R, Kachhawa G, Dada R, Kulshreshtha V, Kumari R, et al. Disrupted placental vitamin D metabolism and calcium signaling in gestational diabetes and pre-eclampsia patients. Endocrine. 2023;80(1):191-200. DOI: 10.1007/s12020-022-03272-9.
  29. Wang Y, Wang T, Huo Y, Liu L, Liu S, Yin X, et al. Placenta expression of vitamin D and related genes in pregnant women with gestational diabetes mellitus. J Steroid Biochem Mol Biol. 2020;204:105754. DOI: 10.1016/j.jsbmb.2020.105754.
  30. Pineda-Lancheros LE, Gálvez-Navas JM, Rojo-Tolosa S, Membrive-Jiménez C, Valverde-Merino MI, Martínez-Martínez F, et al. Polymorphisms in VDR, CYP27B1, CYP2R1, GC and CYP24A1 Genes as Biomarkers of Survival in Non-Small Cell Lung Cancer: A Systematic Review. Nutrients. 2023;15(6):1525. DOI: 10.3390/nu15061525.

Publication of the article:

«Bulletin of problems biology and medicine», 2025 Issue 1, 176, 288-297 pages, index UDC 618.3/.5-06:616.12-008.331.1-07-085:577.161.2

DOI:

10.29254/2077-4214-2025-1-176-288-297

Was this article helpful?

Leave a Reply

Your email address will not be published. Required fields are marked *


The reCAPTCHA verification period has expired. Please reload the page.